Table 3.
Prevalence of cardiovascular risk factors and lipid profile
| Total (%) | Gender* | Age* | MTHFR C677T genotype* | ||||||
| Male | Female | 13 | 14 | >14 | CC | CT | TT | ||
| Overweight | 30.3 | 35.9 | 25.6 | ns | ns | ||||
| Hypertension | 8.5 | ns | ns | ns | |||||
| Glucose (≥ 100 mg/dl) | 15.3 | 22 | 9.6 | ns | ns | ||||
| Total cholesterol (≥ 200 mg/dl) | 7.0 | 2.8 | 10.5 | ns | ns | ||||
| HDL cholesterol (≤ 35 mg/dl) | 13.8 | 20.1 | 8.3 | ns | ns | ||||
| LDL cholesterol (≥ 130 mg/dl) | 6.4 | ns | ns | ns | |||||
| Total cholesterol/cHDL (>5en ♂/4.5 en ♀) |
9.1 | ns | ns | ns | |||||
| cLDL/cHDL (>3.5 ♂/3 ♀) |
8.5 | ns | ns | ns | |||||
| Smoking | 7.6 | ns | 3.2 | 14.5 | 19.1 | ns | |||
| Alcohol | 9.8 | ns | 1.9 | 12.5 | 12.8 | ns | |||
| Sedentariness | 17.7 | 9 | 25.1 | ns | ns | ||||
| Folate (≤ 5.3 nmol/l) | 23.8 | ns | ns | 18.8 | 20.4 | 46.7** | |||
| Vitamin B12 (≤ 336 pmol/l) |
24.6 | 30.3 | 10 | ns | ns | ||||
*Statistically significant p < 0.05. ns: non-significant; ** differences in folate deficit were statistically significant (p < 0.001) only for homozygotic TT mutation. CT heterozygotic mutation does not show an statistically significant difference (p = 0.758)
HDL: High Density Lipoproteins
LDL: Low Density Lipoproteins
MTHFR: methylenetetrahydrofolate reductase
C: Cytosine; T:Thymine